Skip to main content
. Author manuscript; available in PMC: 2015 Dec 23.
Published in final edited form as: Chem Rev. 2015 Jul 8;115(19):11109–11146. doi: 10.1021/acs.chemrev.5b00109

Figure 11.

Figure 11

Carbon nanoparticles for oral vaccination. (A) Schematic of carbonization mechanism for formation of mesoporous carbon nanoparticles (C1). (B) Mean serum anti-BSA IgG profile of mice after: i.m. administration of BSA emulsified in Complete Freund’s Adjuvant (FCA), oral administration of soluble BSA, or oral administration of BSA loaded in carbon nanoparticles (C1). Prime and boost immunizations were spaced three weeks apart. Adapted from Wang et al.193 Reprinted with permission from reference 193. Copyright 2011 Elsevier B.V.